Lionel ARNAUD

Lionel ARNAUD has a diverse work experience spanning various industries and roles.

Lionel is currently serving as the Chief Operating Officer at Biomemory since October 2022. Prior to this, they worked at Par'Immune as the Chief Operating Officer from April 2018 to September 2022.

From 2014, Lionel ARNAUD worked at the European Commission where they held the roles of Project Monitor and Expert Evaluator.

Before that, they had an extensive tenure at F. Iniciativas, starting as a Research Consultant in Innovation's Non-Dilutive Funding in September 2012. Lionel then progressed to the roles of Senior Consultant in Innovation Public Funding, Team Leader, and Manager. At F. Iniciativas, they managed a portfolio of clients, supervised business plans and projects, and contributed to the growth and development of the business unit.

Additionally, Lionel ARNAUD worked as a Consultant in Innovation's Non-Dilutive Funding at EURINNOV, where they managed clients' portfolios, searched for partners, and facilitated project applications.

In the academic field, Lionel ARNAUD worked as an Associate Researcher at the Mount Sinai School of Medicine, focusing on developmental and regenerative biology. Lionel conducted experiments, analyzed data, and presented results.

Lionel also gained experience at ShigaMediX as an Administrative and Financial Assistant, Paris Biotech Santé as a Business Developer, and AstraZeneca as a Financial Controller (Trainee).

Furthermore, Lionel ARNAUD had a research trainee position at the Collège de France.

Overall, Lionel ARNAUD's work experience showcases a strong background in leadership, project management, funding strategies, and scientific research across various sectors.

Lionel ARNAUD's education history is as follows:

Lionel ARNAUD obtained a Maîtrise (Master1) degree in Economics and Business Administration from Sorbonne University, where they studied from 2002 to 2006. Lionel then pursued a Master 2 (postgraduate) degree in Technologies and Innovation Management at Université Paris Dauphine - PSL from 2006 to 2007.

In 2009, Lionel ARNAUD participated in an exchange program from Denis Diderot University in Paris, France, and earned a Licence degree in Cellular Biology and Physiology as well as Biology and Biochemistry from The City University of New York, completing their studies in 2010.

To further develop their skills and knowledge, Lionel ARNAUD obtained additional certifications. In 2015, they completed the CS50X: Introduction to Computer Science course at Harvard University. In 2018, they obtained the Design and Interpretation of Clinical Trials certification from John Hopkins University and completed the Développer sa pensée critique course at Université libre de Bruxelles. In 2019, they earned the International Certificate in Corporate Finance (ICCF) from HEC Paris. More recently, in 2020, Lionel ARNAUD obtained a certification in Immunological Therapies from Université Paris Descartes, followed by a certification in Stratégies diagnostiques des cancers from Université Paris Cité in 2022.